Literature DB >> 9030587

Hepatocyte growth factor promotes motor neuron survival and synergizes with ciliary neurotrophic factor.

V Wong1, D J Glass, R Arriaga, G D Yancopoulos, R M Lindsay, G Conn.   

Abstract

Hepatocyte growth factor (HGF) has been shown to function as a potent mitogen for a variety of cells, transducing its signal through the c-met tyrosine kinase receptor. Ciliary neurotrophic factor (CNTF) is a cytokine that has been shown to promote survival of motor neurons. We show here that c-met mRNA is present in the embryonic rat spinal cord. Peak expression of c-met (at E14) coincides with the period of naturally occurring cell death in motor neurons, suggesting a possible role of HGF in the regulation of this process. Utilizing a neuron-enriched culture system, we established that HGF, like CNTF, stimulates choline acetyltransferase (CAT) activity in motor neurons. When co-administered to motor neuron cultures, saturating concentrations of HGF and CNTF produced a synergistic increase in CAT levels. We show that this synergy reflects enhanced motor neuron survival. Exposure of motor neuron cultures to the cytostatic agent vincristine markedly decreased CAT levels; co-treatment with HGF and CNTF (but not either factor alone) restored CAT activity to control levels. Our findings indicate that HGF is a survival factor for motor neurons, that it acts synergistically with CNTF, and that HGF and CNTF can together be neuroprotective in the face of vincristine toxicity.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9030587     DOI: 10.1074/jbc.272.8.5187

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  24 in total

Review 1.  Motor neuron trophic factors: therapeutic use in ALS?

Authors:  Thomas W Gould; Ronald W Oppenheim
Journal:  Brain Res Rev       Date:  2010-10-21

2.  Autocrine hepatocyte growth factor provides a local mechanism for promoting axonal growth.

Authors:  X M Yang; J G Toma; S X Bamji; D J Belliveau; J Kohn; M Park; F D Miller
Journal:  J Neurosci       Date:  1998-10-15       Impact factor: 6.167

3.  Hepatocyte growth factor/scatter factor is a neurotrophic survival factor for lumbar but not for other somatic motoneurons in the chick embryo.

Authors:  K D Novak; D Prevette; S Wang; T W Gould; R W Oppenheim
Journal:  J Neurosci       Date:  2000-01-01       Impact factor: 6.167

4.  Hepatocyte growth factor is a mitogen for olfactory ensheathing cells.

Authors:  H Yan; X Nie; J D Kocsis
Journal:  J Neurosci Res       Date:  2001-11-15       Impact factor: 4.164

5.  MAOA promotes prostate cancer cell perineural invasion through SEMA3C/PlexinA2/NRP1-cMET signaling.

Authors:  Lijuan Yin; Jingjing Li; Jing Wang; Tianjie Pu; Jing Wei; Qinlong Li; Boyang Jason Wu
Journal:  Oncogene       Date:  2021-01-08       Impact factor: 9.867

6.  Cyclic AMP elevation is sufficient to promote the survival of spinal motor neurons in vitro.

Authors:  M G Hanson; S Shen; A P Wiemelt; F A McMorris; B A Barres
Journal:  J Neurosci       Date:  1998-09-15       Impact factor: 6.167

7.  Neurotrophic growth factors for the treatment of amyotrophic lateral sclerosis: where do we stand?

Authors:  Alexandre Henriques; Claudia Pitzer; Armin Schneider
Journal:  Front Neurosci       Date:  2010-06-11       Impact factor: 4.677

Review 8.  MET receptor tyrosine kinase as an autism genetic risk factor.

Authors:  Yun Peng; Matthew Huentelman; Christopher Smith; Shenfeng Qiu
Journal:  Int Rev Neurobiol       Date:  2013       Impact factor: 3.230

9.  Haploinsufficiency of c-Met in cd44-/- mice identifies a collaboration of CD44 and c-Met in vivo.

Authors:  Alexandra Matzke; Vardanush Sargsyan; Bettina Holtmann; Gayane Aramuni; Esther Asan; Michael Sendtner; Giuseppina Pace; Norma Howells; Weiqi Zhang; Helmut Ponta; Véronique Orian-Rousseau
Journal:  Mol Cell Biol       Date:  2007-10-08       Impact factor: 4.272

10.  Phase 1/2 open-label dose-escalation study of plasmid DNA expressing two isoforms of hepatocyte growth factor in patients with painful diabetic peripheral neuropathy.

Authors:  Senda Ajroud-Driss; Mark Christiansen; Jeffrey A Allen; John A Kessler
Journal:  Mol Ther       Date:  2013-04-23       Impact factor: 11.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.